熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
加拿大IntelGenx
IntelGenx是蒙特利爾的公司,致力于開發(fā)其新穎和創(chuàng)新的專有技術(shù),為提高藥物輸送。我們的經(jīng)營(yíng)策略是運(yùn)用我們專有的給藥技術(shù),以改善現(xiàn)有的藥物化合物,并證明療效和安全性,發(fā)展戰(zhàn)略和分銷合作伙伴一起,這些藥物化合物的品牌產(chǎn)品,提高了產(chǎn)能和效能重新市場(chǎng)。IntelGenx是能夠通過自身和戰(zhàn)略合作伙伴,其合作伙伴提供完整的服務(wù)制藥
IntelGenx is a Montreal based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery.
Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy.
IntelGenx is capable, through itself and strategic partners, of offering its partners full service pharmaceutical development from formulation development, clinical development and regulatory activities to manufacturing and packaging.
IntelGenx’s highly qualified team has the capability to work with new chemical entities (NCEs) or established therapeutic active pharmaceutical ingredients (APIs) where the use of innovative new drug delivery systems offer significant competitive advantage or the opportunity for product extension and life cycle management.